Author

Kathryn Burke

Observed names: K. Burke, Kathryn N. Burke

Institution: RTI International

Observed institutions: Johns Hopkins University, RTI International, George Washington University, Case Western Reserve University

ORCID: 0009-0002-4920-6627

Observed ORCID: 0009-0002-4920-6627

OpenAlex ID: A5033748411

Progression of Geographic Atrophy in Age-related Macular Degeneration

2018 · Tiarnan D. Keenan, Elvira Agrón, et al. · Ophthalmology · 225

Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials

2015 · Alex S. Willoughby, Gui-shuang Ying, et al. · Ophthalmology · 224

Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration

2018 · Jeannette J. Yu, Elvira Agrón, et al. · Ophthalmology · 60

Outcomes of Eyes with Lesions Composed of >50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

2014 · Michael M. Altaweel, Ebenezer Daniel, et al. · Ophthalmology · 51

Cyclin-Dependent Kinase 5 Mediates Adult OPC Maturation and Myelin Repair through Modulation of Akt and GsK-3 Signaling

2014 · F. Luo, K. Burke, et al. · Journal of Neuroscience · 49

The Activators of Cyclin-Dependent Kinase 5 p35 and p39 Are Essential for Oligodendrocyte Maturation, Process Formation, and Myelination

2016 · Fucheng Luo, Jessie Zhang, et al. · Journal of Neuroscience · 32

Predominantly Persistent Intraretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments Trials

2022 · Jason Q. Core, Maxwell Pistilli, et al. · Ophthalmology Retina · 23

Oligodendrocyte-specific loss of Cdk5 disrupts the architecture of nodes of Ranvier as well as learning and memory

2018 · Fucheng Luo, Jessie Zhang, et al. · Experimental Neurology · 23

Prediction for 2-Year Vision Outcomes Using Early Morphologic and Functional Responses in the Comparison of Age-related Macular Degeneration Treatments Trials

2023 · Katie Xue, Peiying Hua, et al. · Ophthalmology Retina · 9

Barriers and facilitators to use of buprenorphine in state-licensed specialty substance use treatment programs: A survey of program leadership

2024 · Kathryn N. Burke, Noa Krawczyk, et al. · Journal of Substance Use and Addiction Treatment · 6

Validation of Medicaid claim-based opioid treatment program retention quality measures

2026 · Kathryn N. Burke, Tami L. Mark, et al. · Journal of Substance Use and Addiction Treatment · 1

Variation in 90‐day substance use disorder‐related acute care events across United States opioid treatment programs: A Medicaid claims analysis

2026 · Barrett Wallace Montgomery, Tami L. Mark, et al. · Addiction

Localized, Ubiquitous Cell Ablation as a Novel, Non-Traumatic Model for Brain Atrophy

2016 · Kathryn Burke, Molly Karl, et al.

Ablating Oligodendrocytes in the Optic Nerve as a Model to Study Demyelination

2016 · Ahdeah Pajoohesh‐Ganji, Molly Karl, et al.

Effects development has on the redistribution of tubulin in sea urchin embryos.

2009 · Kathryn Burke · Wheaton College Digital Repository (Wheaton College (MA))

Works count: 15

Citation count: 703

H-index: 9

I10-index: 8